<strong>Objectives: </strong>To enhance understanding of COVID-19 in clinical characteristics, related organ system dysfunctions and therapies. <strong>Methods: </strong>We enrolled patients wi...<strong>Objectives: </strong>To enhance understanding of COVID-19 in clinical characteristics, related organ system dysfunctions and therapies. <strong>Methods: </strong>We enrolled patients with COVID-19 admitted to two Chinese hospitals from 19 January 2020 to 15 March 2020 and collected demographic and clinical data. <strong>Results:</strong> We retrospectively enrolled 130 patients: 7 mild, 103 moderate, and 20 severe cases. Severe patients were older than mild/moderate patients (60.1 vs 52.9 years;P = 0.028) and had more comorbidities (85.0% vs 52.7%;p = 0.006). 116 patients (89.2%) were 2019-noval coronavirus RNA-positive with a median detectable time of 10 days. Obvious absorbed of pneumonia in chest imaging occurred in 20 days. The most common symptoms were fever (n = 87, 66.9%), cough (n = 74, 56.9%), fatigue (n = 73, 56.2%), and chest tightness (n = 54, 41.5%). The incidence of liver, kidney, heart, and coagulation dysfunction was 38.4%, 24.5%, 30.1%, and 24.6%, respectively. The most frequently used antiviral therapies were arbidol (n = 64, 49.2%), oseltamivir (n = 73, 56.2%), and Lianhua Qingwen (n = 73, 56.2%). All patients recovered being hospitalized with a median duration of 15 days. <strong>Conclusions:</strong> Middle-aged and elderly with comorbidities are more likely to be infected with COVID-19 and develop severe symptoms. The lung, liver, heart, kidney, and coagulation system all may sustain injury, especially in severe cases.展开更多
文摘<strong>Objectives: </strong>To enhance understanding of COVID-19 in clinical characteristics, related organ system dysfunctions and therapies. <strong>Methods: </strong>We enrolled patients with COVID-19 admitted to two Chinese hospitals from 19 January 2020 to 15 March 2020 and collected demographic and clinical data. <strong>Results:</strong> We retrospectively enrolled 130 patients: 7 mild, 103 moderate, and 20 severe cases. Severe patients were older than mild/moderate patients (60.1 vs 52.9 years;P = 0.028) and had more comorbidities (85.0% vs 52.7%;p = 0.006). 116 patients (89.2%) were 2019-noval coronavirus RNA-positive with a median detectable time of 10 days. Obvious absorbed of pneumonia in chest imaging occurred in 20 days. The most common symptoms were fever (n = 87, 66.9%), cough (n = 74, 56.9%), fatigue (n = 73, 56.2%), and chest tightness (n = 54, 41.5%). The incidence of liver, kidney, heart, and coagulation dysfunction was 38.4%, 24.5%, 30.1%, and 24.6%, respectively. The most frequently used antiviral therapies were arbidol (n = 64, 49.2%), oseltamivir (n = 73, 56.2%), and Lianhua Qingwen (n = 73, 56.2%). All patients recovered being hospitalized with a median duration of 15 days. <strong>Conclusions:</strong> Middle-aged and elderly with comorbidities are more likely to be infected with COVID-19 and develop severe symptoms. The lung, liver, heart, kidney, and coagulation system all may sustain injury, especially in severe cases.
